Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2008
03/20/2008CA2663502A1 Azetidinone derivatives and methods of use thereof
03/20/2008CA2663501A1 Treating pain, diabetes, and disorders of lipid metabolism
03/20/2008CA2663500A1 Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism
03/20/2008CA2663474A1 Pro-oxidant anti-cancer compounds
03/20/2008CA2663434A1 Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders
03/20/2008CA2663417A1 Methods and compositions for sealing and adhering biological tissues and medical uses thereof
03/20/2008CA2663376A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
03/20/2008CA2663375A1 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions
03/20/2008CA2663311A1 Pharmaceutical formulations comprising clopidogrel
03/20/2008CA2663297A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders
03/20/2008CA2663280A1 Diaryl piperidine compounds as calcium channel blockers
03/20/2008CA2663279A1 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,-4-dioxo-3,4-dihydro-2h-pyridimin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer,autoimmune disorders and hiv infection
03/20/2008CA2663254A1 Synthesis, methods of using, and compositions of cycloalkylmethylamines
03/20/2008CA2663234A1 Novel phenylacetic acid derivative
03/20/2008CA2663206A1 Treatment of vertigo with acetyl-l-leucine
03/20/2008CA2663193A1 2-(1-oxo-1h-isoquinolin-2-yl)acetamide derivatives
03/20/2008CA2663189A1 Benzimidazolone derivatives
03/20/2008CA2663178A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10
03/20/2008CA2663172A1 Abuse resistant drug formulation
03/20/2008CA2663161A1 Quinazolinone and isoquinolinone acetamide derivatives
03/20/2008CA2663147A1 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
03/20/2008CA2663129A1 Nitrate esters of aminoalcohols
03/20/2008CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
03/20/2008CA2662981A1 Targeted polymeric prodrugs containing multifunctional linkers
03/20/2008CA2662978A1 Hindered ester-based biodegradable linkers for oligonucleotide delivery
03/20/2008CA2662973A1 Lysine-based polymeric linkers
03/20/2008CA2662962A1 Polyalkylene oxides having hindered ester-based biodegradable linkers
03/20/2008CA2662956A1 Oral modified release formulations
03/20/2008CA2662938A1 Light-stable solid pharmaceutical composition of ramosetron
03/20/2008CA2662937A1 Multi-functional small molecules as anti-proliferative agents
03/20/2008CA2662920A1 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
03/20/2008CA2662879A1 2-phenoxynicotinic acid derivatives and use thereof
03/20/2008CA2662878A1 4-phenoxynicotinic acid derivatives and use thereof
03/20/2008CA2662617A1 Quinazoline based egfr inhibitors containing a zinc binding moiety
03/20/2008CA2662587A1 Quinazoline based egfr inhibitors
03/20/2008CA2662580A1 Tyrosine kinase inhibitors containing a zinc binding moiety
03/20/2008CA2662565A1 Process for the preparation of an (rp)-8-substituted camps
03/20/2008CA2662554A1 Compounds for the treatment of angiogenesis
03/20/2008CA2662542A1 Pharmaceutical composition comprising a plurality of mini-tablets comprising a factor xa inhibitor
03/20/2008CA2662538A1 Azabicyclic compounds as inhibitors of monoamines reuptake
03/20/2008CA2662520A1 Polymeric conjugates containing positively-charged moieties
03/20/2008CA2662432A1 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors
03/20/2008CA2662430A1 Methods of treatment for ulcerative colitis using aminosalicylate
03/20/2008CA2662428A1 Methods of treatment for ulcerative colitis
03/20/2008CA2662409A1 5-phenyl-nicotinamide derivatives
03/20/2008CA2662115A1 Methods for enhancing cognitive function
03/20/2008CA2662104A1 Adenosine derivatives as a2a receptor agonists
03/20/2008CA2662099A1 Pyridine- and quinoline-pyrimidine-derivatives
03/20/2008CA2661938A1 Pyrimidines derivatives and their use as kinase inhibitors
03/20/2008CA2661892A1 Gel type enteral nutrient
03/20/2008CA2661654A1 Certain substituted amides, method of making, and method of use thereof
03/20/2008CA2660987A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors
03/20/2008CA2660611A1 Thiadiazole compound and use thereof
03/20/2008CA2659070A1 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors
03/19/2008EP1900827A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
03/19/2008EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing
03/19/2008EP1900746A1 Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent
03/19/2008EP1900742A1 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
03/19/2008EP1900741A1 New process for the production of oxabispidines
03/19/2008EP1900739A1 Diazolodiazine derivatives as kinase inhibitors
03/19/2008EP1900738A2 Substituted pyrroline kinase inhibitors
03/19/2008EP1900737A1 Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
03/19/2008EP1900736A1 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
03/19/2008EP1900732A1 Novel nitrogenated heterocyclic compound and salt thereof
03/19/2008EP1900731A1 N-(1-Phthalazin-1-yl-piperidin-4-yl)-amides as EP2-receptor modulators
03/19/2008EP1900729A1 Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors
03/19/2008EP1900728A1 Pharmaceutical composition comprising pyrazolone derivative
03/19/2008EP1900727A1 Aminopyridine derivatives as kinase inhibitors
03/19/2008EP1900726A1 Heterocyclic thioesters
03/19/2008EP1900721A1 Substituted cyclic compound, its preparation process and its medical use
03/19/2008EP1900380A1 Pharmaceutical composition for vascular occlusive disease
03/19/2008EP1900378A1 Pharmaceutical compositions for the treatment of fungal infections
03/19/2008EP1900377A1 Inhibitors of GPR87 for cancer therapy
03/19/2008EP1900375A1 Calreticulin for its use as a medication for the treatment of cancer in a mammal
03/19/2008EP1900369A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
03/19/2008EP1900368A1 Tablet containing hardly soluble active ingredient
03/19/2008EP1900367A2 Hypoglycemic agent
03/19/2008EP1900366A2 Hypoglycemic agent
03/19/2008EP1900365A2 New endocannabinoid-like compounds and their use
03/19/2008EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/19/2008EP1900363A1 Therapeutic agent for pain
03/19/2008EP1900362A2 Alfa-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
03/19/2008EP1900361A1 Solution for canal irrigation based on sodium hypochlorite and proteolytic enzyme
03/19/2008EP1900360A1 Homer a new target of treating psychiatric disorders
03/19/2008EP1900358A1 Pharmaceutical formulations comprising clopidogrel
03/19/2008EP1899480A1 Compositions and methods for treating inflammatory conditions
03/19/2008EP1899451A1 Methods and compositions for regulating biofilm development
03/19/2008EP1899355A1 Thienopyrimidine and thienopyridine derivatives as flt-3 kinase inhibitors
03/19/2008EP1899353A1 Thienopyrimidines for pharmaceutical compositions
03/19/2008EP1899352A1 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors
03/19/2008EP1899350A1 Pyrazolo ý3 , 4-d¨azepine derivatives as histamine h3 antagonists
03/19/2008EP1899348A1 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
03/19/2008EP1899346A1 Pyrrolotriazine compounds useful as kinase inhibitors
03/19/2008EP1899345A1 Pyrrolotriazine compounds useful as kinase inhibitors
03/19/2008EP1899343A1 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates
03/19/2008EP1899341A1 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors
03/19/2008EP1899339A1 1,2-dihydro-spiro(3h-indole-3-4 -piperidine) compounds as modulators of the mas receptor novel
03/19/2008EP1899338A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion
03/19/2008EP1899336A1 Cysteine protease inhibitors
03/19/2008EP1899335A1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors
1 ... 3334 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 ... 7860